تحميل...
Long-term treatment with tocilizumab in giant cell arteritis: efficacy and safety in a monocentric cohort of patients
OBJECTIVE: The efficacy of tocilizumab (TCZ) in GCA is supported by two randomized controlled studies, in which TCZ allowed remission to be achieved after 52 weeks of treatment. However, after discontinuation of treatment, half of the patients relapsed. The aim of this study was to analyse the effic...
محفوظ في:
| الحاوية / القاعدة: | Rheumatol Adv Pract |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Oxford University Press
2020
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7359771/ https://ncbi.nlm.nih.gov/pubmed/32685912 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rap/rkaa017 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|